Loading...

Merit Medical Systems, Inc. Peer Comparison

Metric Value Ranking
Market Cap $6.3 Billion 6/11 RMD
$34.2B
COO
$17.6B
WST
$15.6B
ATR
$9.6B
TFX
$7.8B
MMSI
$6.3B
ICUI
$3.9B
NVST
$3.7B
XRAY
$3.6B
HAE
$3.1B
ANGO
$418.4M
Gross Margin 46% 8/11 COO
67%
RMD
59%
HAE
56%
TFX
56%
ANGO
55%
NVST
53%
XRAY
52%
MMSI
46%
ATR
39%
WST
35%
ICUI
35%
Profit Margin 8% 7/11 RMD
27%
WST
18%
TFX
15%
COO
12%
ATR
12%
HAE
11%
MMSI
8%
NVST
1%
ICUI
-6%
ANGO
-15%
XRAY
-52%
EBITDA margin 22% 3/11 RMD
28%
ATR
23%
MMSI
22%
WST
22%
COO
19%
HAE
17%
TFX
15%
NVST
10%
XRAY
7%
ICUI
1%
ANGO
-3%
Quarterly Revenue $339.8 Million 10/11 RMD
$1.3B
COO
$1.0B
XRAY
$951.0M
ATR
$848.1M
TFX
$764.4M
WST
$746.9M
NVST
$601.0M
ICUI
$589.1M
HAE
$348.5M
MMSI
$339.8M
ANGO
$72.8M
Quarterly Earnings $28.4 Million 7/11 RMD
$344.6M
WST
$136.0M
COO
$117.5M
TFX
$111.0M
ATR
$100.9M
HAE
$37.5M
MMSI
$28.4M
NVST
$8.2M
ANGO
-$10.7M
ICUI
-$33.0M
XRAY
-$494.0M
Quarterly Free Cash Flow $37.4 Million 7/11 WST
$370.9M
TFX
$306.6M
RMD
$289.7M
ATR
$107.7M
XRAY
$98.0M
NVST
$63.3M
MMSI
$37.4M
HAE
$35.2M
ICUI
$21.6M
ANGO
$1.7M
COO
-$0
Trailing 4 Quarters Revenue $1.3 Billion 10/11 RMD
$4.9B
ATR
$3.6B
TFX
$3.0B
COO
$3.0B
XRAY
$2.9B
WST
$2.9B
NVST
$2.8B
ICUI
$2.3B
HAE
$1.4B
MMSI
$1.3B
ANGO
$286.5M
Trailing 4 Quarters Earnings $120.0 Million 7/11 RMD
$1.3B
COO
$1.0B
XRAY
$951.0M
ATR
$848.1M
TFX
$764.4M
WST
$746.9M
NVST
$601.0M
ICUI
$589.1M
HAE
$348.5M
MMSI
$339.8M
ANGO
$72.8M
Quarterly Earnings Growth 10% 6/11 RMD
65%
ANGO
63%
ATR
62%
COO
39%
HAE
20%
MMSI
10%
WST
-16%
TFX
-19%
NVST
-62%
XRAY
-86%
ICUI
-556%
Annual Earnings Growth 39% 2/11 RMD
44%
MMSI
39%
HAE
23%
ATR
19%
COO
15%
WST
-20%
TFX
-50%
ANGO
-307%
ICUI
-392%
NVST
-855%
XRAY
-5900%
Quarterly Revenue Growth 8% 3/11 RMD
10%
COO
10%
MMSI
8%
ICUI
6%
HAE
4%
TFX
2%
ATR
1%
XRAY
0%
WST
0%
NVST
-5%
ANGO
-8%
Annual Revenue Growth 4% 5/11 RMD
22%
NVST
7%
HAE
6%
ICUI
6%
MMSI
4%
TFX
2%
ATR
2%
WST
-4%
ANGO
-9%
COO
-20%
XRAY
-28%
Cash On Hand $523.1 Million 2/11 NVST
$991.3M
MMSI
$523.1M
RMD
$521.9M
WST
$490.9M
HAE
$320.8M
ICUI
$312.5M
XRAY
$296.0M
TFX
$243.2M
ATR
$223.8M
COO
$107.6M
ANGO
$54.1M
Short Term Debt $11.5 Million 8/11 XRAY
$422.0M
NVST
$115.8M
TFX
$96.9M
ICUI
$51.0M
RMD
$37.7M
COO
$33.3M
WST
$19.9M
MMSI
$11.5M
HAE
$5.1M
ANGO
-$0
ATR
-$0
Long Term Debt $750.5 Million 8/11 COO
$2.6B
XRAY
$1.9B
TFX
$1.8B
ICUI
$1.5B
NVST
$1.3B
HAE
$1.2B
RMD
$802.0M
MMSI
$750.5M
ATR
$688.1M
WST
$284.9M
ANGO
$0
PE 52.50 1/11 MMSI
52.50
COO
44.82
TFX
32.75
WST
31.13
RMD
27.40
ATR
25.71
HAE
24.09
XRAY
-1.00
ANGO
-1.00
ICUI
-1.00
NVST
-1.00
PS 4.75 4/11 RMD
6.95
COO
5.93
WST
5.41
MMSI
4.75
ATR
2.69
TFX
2.57
HAE
2.28
ICUI
1.68
ANGO
1.46
NVST
1.32
XRAY
1.25
PB 4.76 3/11 RMD
6.51
WST
5.65
MMSI
4.76
ATR
3.87
HAE
3.45
ANGO
2.24
COO
2.18
ICUI
1.91
TFX
1.74
XRAY
1.46
NVST
1.21
PC 12.05 8/11 COO
163.41
RMD
65.56
ATR
43.01
TFX
31.97
WST
31.68
ICUI
12.55
XRAY
12.30
MMSI
12.05
HAE
9.76
ANGO
7.74
NVST
3.76
Liabilities to Equity 0.80 4/11 HAE
1.79
XRAY
1.66
ICUI
1.10
MMSI
0.80
ATR
0.79
NVST
0.79
TFX
0.67
ANGO
0.56
COO
0.52
RMD
0.36
WST
0.34
ROA 0.05 4/11 RMD
17%
WST
14%
ATR
8%
MMSI
5%
HAE
5%
COO
3%
TFX
3%
ICUI
-3%
XRAY
-7%
NVST
-24%
ANGO
-77%
ROE 0.09 5/11 RMD
24%
WST
18%
ATR
15%
HAE
14%
MMSI
9%
COO
5%
TFX
5%
ICUI
-5%
XRAY
-19%
NVST
-44%
ANGO
-120%
Current Ratio 2.25 8/11 WST
3.98
RMD
3.78
COO
2.91
ANGO
2.78
TFX
2.49
ATR
2.28
NVST
2.26
MMSI
2.25
ICUI
1.91
XRAY
1.60
HAE
1.56
Quick Ratio 0.50 3/11 MMSI
52.50
COO
44.82
TFX
32.75
WST
31.13
RMD
27.40
ATR
25.71
HAE
24.09
XRAY
-1.00
ANGO
-1.00
ICUI
-1.00
NVST
-1.00
Long Term Debt to Equity 0.57 4/11 HAE}
1.35
XRAY}
0.76
ICUI}
0.75
MMSI}
0.57
NVST}
0.42
TFX}
0.39
COO}
0.32
ATR}
0.28
RMD}
0.15
WST}
0.10
ANGO}
0.00
Debt to Equity 0.57 4/11 HAE
1.35
XRAY
0.93
ICUI
0.78
MMSI
0.57
NVST
0.46
TFX
0.42
COO
0.32
ATR
0.28
RMD
0.16
WST
0.11
ANGO
0.00
Burn Rate 117.73 1/11 MMSI
117.73
HAE
25.53
NVST
13.58
ANGO
5.04
ICUI
2.91
XRAY
0.44
RMD
-1.72
ATR
-3.05
WST
-4.10
TFX
-15.01
COO
-15.03
Cash to Cap 0.08 4/11 NVST
0.27
ANGO
0.13
HAE
0.10
MMSI
0.08
XRAY
0.08
ICUI
0.08
TFX
0.03
WST
0.03
RMD
0.02
ATR
0.02
COO
0.01
CCR 1.32 4/11 NVST
7.72
TFX
2.76
WST
2.73
MMSI
1.32
ATR
1.07
HAE
0.94
RMD
0.84
ANGO
-0.16
XRAY
-0.20
ICUI
-0.65
COO
EV to EBITDA 88.79 5/11 ICUI}
631.77
COO}
101.11
RMD}
95.35
WST}
95.26
MMSI}
88.79
XRAY}
87.16
TFX}
84.69
NVST}
70.63
HAE}
68.39
ATR}
51.78
ANGO}
-145.27
EV to Revenue 4.93 4/11 RMD
7.01
COO
6.77
WST
5.34
MMSI
4.93
TFX
3.10
HAE
2.94
ATR
2.82
ICUI
2.22
XRAY
1.95
NVST
1.48
ANGO
1.27